It's PRIMETIME. Postoperative Avoidance of Radiotherapy: Biomarker Selection of Women at Very Low Risk of Local Recurrence-Reference-Cited by-同舟云学术

It's PRIMETIME. Postoperative Avoidance of Radiotherapy: Biomarker Selection of Women at Very Low Risk of Local Recurrence

Published:2016-09 Issue:9 Volume:28 Page:594-596
ISSN:0936-6555
Container-title:Clinical Oncology
language:en
Short-container-title:Clinical Oncology

Author:

Kirwan C.C.^ORCID,Coles C.E.,Bliss J.,Kirwan C.,Kilburn L.,Fox L.,Cheang M.,Griffin C.,Francis A.,Kirby A.,Ah-See M.,Sharma R.,Mukesh M.,Twyman N.,Loane J.,Dodson A.,Provenzano E.,Kunkler I.,Yarnold J.,Pharoah P.,Caldas C.,Stobart H.,Turner L.,Megias D.,Bliss J.,Coles C.E.

Funder

Cancer Research UK

Cambridge National Institute of Health Research Biomedical Research Centre

National Institute of Health Research Clinician Scientist Award

Publisher

Elsevier BV

Subject

Radiology, Nuclear Medicine and imaging,Oncology

Reference9 articles.

1. Effect of radiotherapy after breast-conserving surgery on 10-year recurrence and 15-year breast cancer death: meta-analysis of individual patient data for 10,801 women in 17 randomised trials;Darby;Lancet,2011

2. Breast-conserving surgery with or without irradiation in women aged 65 years or older with early breast cancer (PRIME II): a randomised controlled trial;Kunkler;Lancet Oncol,2015

3. The UK Standardisation of Breast Radiotherapy (START) trials of radiotherapy hypofractionation for treatment of early breast cancer: 10-year follow-up results of two randomised controlled trials;Haviland;Lancet Oncol,2013